Recently, Satow et al. [19] have demonstrated an aberrant overexpression of TPX2 in HCC through combined functional genome survey, but the clinical significance of TPX2 and its role in HCC are poorly understood. This evidence concerns the gene TPX2 and hepatocellular carcinoma.